Important Safety Information

• PRASCEND is for use in horses only.
• PRASCEND has not been evaluated in breeding, pregnant, or lactating horses.
• Treatment with PRASCEND may cause loss of appetite. Most cases are mild. If severe, a temporary dose reduction may be necessary. Weight loss, lack of energy, and behavioral changes also may be observed.
• PRASCEND is contraindicated in horses with hypersensitivity to pergolide mesylate or other ergot derivatives.
• Not for use in humans. Do not ingest the product.
• PRASCEND tablets should not be crushed due to the potential for increased human exposure.
• Pergolide, like other ergot derivatives, may cause emesis, dizziness, lethargy or low blood pressure.
• Pregnant or lactating women should wear gloves when administering this product.
• Store this product separately away from human medicinal products and handle this product with care to avoid accidental ingestion.
• Keep PRASCEND in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.
• Dogs have eaten PRASCEND tablets that were placed in food intended for horses or dropped during administration of the tablets to the horses.
• Adverse reactions may occur if animals other than horses ingest PRASCEND tablets.
• Refer to the package insert for complete product information.